Malignant Nasal Paraganglioma a Case Report and Review of the Literature
Paragangliomas tin be plant from the skull base of operations to the sacrum. Sinonasal paragangliomas are exceptional. A 16-yr-old female reported spontaneous discrete bilateral epistaxis once a month outset when she was 3 years of age. Computed tomography showed an expansive hypervascular mass occupying the right nasal cavity and nasopharynx. Sinonasal paragangliomas commonly occur in eye-anile women. Radiologic investigation is essential for the diagnosis of sinonasal paragangliomas and evaluating extension of the lesion. Endoscopic and conventional approaches are effective, and preoperative embolization is paramount for reducing haemorrhage risk. Histopathological features cannot differentiate beneficial from malignant paragangliomas, and since metastasis may eventually occur, follow-up must be carried out for a long period of time.
© 2017 The Author(due south) Published by South. Karger AG, Basel
Established Facts
• Paragangliomas are neuroendocrine tumors which can exist establish from the skull base of operations to the sacrum. Sinonasal paragangliomas are infrequent [Tolman and Stam: BJR Case Reports 2016;2016005].
• Their histological features are non accepted equally definitions of malignancy criteria. Malignant paragangliomas are defined by lymph node or distant metastasis and may occur in almost 10% of patients [Pellitteri: Oral Oncol 2004;xl:563-575; Taïeb et al.: J Nucl Med 2012;53:264-274].
• Diagnostic investigation includes catecholamine excess evaluation, computed tomography, and magnetic resonance imaging. Nuclear imaging may be required for secondary lesion investigation. Genetic mutations in the succinate dehydrogenase genes have been described in paraganglioma patients, and those with early on onset should be evaluated when genetic testing is available.
• Sinonasal paragangliomas must be resected, aiming for free margins, either by an endonasal or by conventional arroyo [Ketabchi et al.: Eur Curvation Otorhinolaryngol 2003;260:336-340].
• Radiation therapy may control the disease by slowing its growth rate, just information technology does not provide a cure.
• Follow-up must be carried out over long periods and the time interval between initial treatment and metastasis occurrence has been reported to be every bit long equally 13 years [Michel et al.: J Clin Endocrinol Metab 2013;98:4262-4266].
Novel Insights
• In skull base tumors, stereotactic radiotherapy has been reported favorably [Capatina et al.: Endocr Relat Cancer 2013;xx:291-305].
• Chemotherapy has not demonstrated adequate efficacy [Papaspyrou et al.: Laryngoscope 2013;123:1830-1836]. Somatostatin analogue treatment for tumors positive for its receptor has also not shown an important benefit [Duet et al.: Laryngoscope 2005;115:1381-1384]. Mod antiangiogenic medications may take some promise, but only for paragangliomas of sites other than the head and cervix [Joshua et al.: J Clin Endocrinol Metab 2009;94:5-nine]. Peptide receptor radionuclide therapy with radiolabeled agents (metaiodobenzylguanidine or somatostatin analogue) is an option for cancerous or unresectable paragangliomas with up to half of the cases showing symptomatic and fractional tumor response [Capatina et al.: Endocr Relat Cancer 2013;20:291-305]. Everolimus inhibits mammalian target of rapamycin, a serine-threonine kinase that stimulates cell growth, proliferation, and angiogenesis [Yao et al.: J Clin Oncol 2008;26:4311-4318]. A phase 2 written report evaluating the effect of everolimus in neuroendocrine tumors demonstrated that everolimus treatment presented with high efficacy and tolerability in patients with nonfunctioning neuroendocrine tumors, merely unimposing effectiveness in patients with pheochromocytoma/paraganglioma [Oh et al.: Cancer 2012;118:6162-6170].
Introduction
Paragangliomas originate from pluripotent neural crest stem cells of the autonomic nervous arrangement, known as extra-adrenal paraganglia. Since they may occur anywhere along the paraganglial organization, these tumors can be found from the skull base of operations to the sacrum [1,2].
Head and neck paragangliomas derive from the paraganglia of the parasympathetic nerve in the head, neck, and mediastinum [three]. The four most common sites of evolution are the carotid bifurcation, jugular foramen, vagus nerve, and middle ear. Due to the extensive distribution of the autonomic nervous system, they tin can appear in other locations, such as the orbit, thyroid, larynx, nasopharynx, natural language, and paranasal sinus [1,4,5,6]. Despite its cytoplasmic neurosecretory granules, just 1-3% are functioning paragangliomas with catecholamine secretion [one].
From all paraganglioma sites, around 3% occur in the head and neck, and paragangliomas represent to less than 0.5% of all head and neck tumors, with an estimated clinical incidence of 1/100,000 patients per yr [6,7]. They take a higher predisposition to females, and patients are usually diagnosed in their fifth to seventh decade, and pediatric cases propose genetic predisposition [1,5]. Hereditary paraganglioma incidence is between 10 and l%, which is often multicentric or bilateral, and is more than a decade younger [8,nine]. A positive family unit history increases the risk of multifocality in upwards to 78% of the cases [ix].
Paraganglionic tissue in the nasal crenel of adults has never been reported. The presence of these cells has been reported in stillborn infants, and the origin of paragangliomas of this site has been suggested to derive from residual specialized neural crest cells forth cranial arteries [10,11,12].
Sinonasal paragangliomas are infrequent, with just approximately 40 cases described [5]. Patients often complain about recurrent epistaxis, nasal obstruction, facial swelling, frontal headache, and loss of olfaction [4,13]. These tumors must be differentiated from other sinonasal masses, benign and malignant, such as esthesioneuroblastomas, gliomas, angiofibromas, hemangiopericytomas, rhabdomyosarcomas, and metastases from neuroendocrine tumors [14]. They virtually usually arise from the ethmoid sinus, followed by lateral nasal wall and middle turbinate, and are slow-growing tumors, tending to present in older patients [5]. Sinonasal paragangliomas are almost often diagnosed in heart-aged women with no personal or family history of paragangliomas. The average age at presentation is 45 years, and most patients are betwixt 40 and 60 years quondam [5,xiv,15]. Simply 3 cases of functioning sinonasal paragangliomas have been described: the first presented equally Cushing syndrome and had elevated ACTH levels; the second had a late onset of Cushing's syndrome, presenting 10 years afterward the first resection; and the final was a catecholamine-secreting tumor in a patient with previous diagnosis of abdominal paragangliomas [sixteen,17,eighteen].
Most head and cervix paragangliomas are benign and accept ho-hum progression [2]. Their histological features are not accepted as definitions of malignancy criteria since at that place is non much difference between beneficial and malignant paragangliomas. Cancerous paragangliomas are divers by lymph node or afar metastasis and may occur in about 10% of patients [1,2].
Genetic analyses disclosed the part of mutations in the succinate dehydrogenase (SDH) genes in familial and nonfamilial paragangliomas [xix]. Succinate dehydrogenase enzymatic activity is lost partially or completely in the tumor, despite the typo of gene mutation 8. Five gene loci with autosomal ascendant transmission have been identified for familial paragangliomas: PGL-one, PGL-two, PGL-3, PGL-4, and PGL-5 [three,nine].
Sinonasal paragangliomas are associated with nasal epistaxis, obstruction, facial swelling, pain, and hyposmia [5]. Clinically, they unremarkably are seen equally a cerise polypoid mass fixed to the lateral wall of nasal fossa or on the upper area of nasopharyngeal roof and (sometimes) extending to the paranasal sinuses [10,20,21,22,23,24,25,26,27,28,29,30,31].
Despite rarely existence secretory, all caput and neck paragangliomas should have plasma or 24-h urinary metanephrine or catecholamine concentrations measured [32]. If catecholamine excess is present, synchronous pheochromocytoma or other functional paragangliomas must exist assessed [33].
Pediatric paragangliomas allude genetic predisposition [4] and screening for multiple germline mutations can exist performed, such as SDHB and SDHD, which are the about important for predicting a malignant nature [14,19].
Radiologic investigation is essential for diagnosing sinonasal paragangliomas and evaluates their extension and possible skull base invasion. Angiography is important for defining vascular anatomy preoperatively; demonstrating tumor blood supply, bilateral cognitive blood supply, and possible vessel invasion; and ensuring preoperative embolization, which can reduce intraoperative bleeding [34,35,36].
Nuclear imaging may also be required, particularly in genetic cases, to delineate the extent of the tumor [2] and detect possible synchronous lesions in mutation carries or those at risk (positive family history and young age) [9]. Metaiodobenzylguanidine (123I-MIBG), despite its high specificity, has depression sensitivity for head and cervix paragangliomas, and somatostatin receptor scintigraphy has meliorate sensitivity [37,38].
Due to its higher availability and lower cost, computed tomography (CT) is usually the beginning exam realized and information technology performs a better delineation of osseous structures when compared to magnetic resonance imaging (MRI). On the other paw, MRI is superior for identifying a soft tissue'due south profile and extension [39].
On it histological features, paragangliomas take a typical architecture with the individual tumor cells bundled in nests divided by a fibrovascular stroma, also known every bit a "Zellballen" pattern [1,vi].
Materials and Methods
This article provides a review of sinonasal paraganglioma, as well as reports an illustrative instance of sinonasal paraganglioma and compares it to other similar cases described in the literature. This study was approved by the Brazilian National Cancer Constitute and all participants signed an informed consent understanding.
Case Report
A 16-year-old female presented at the Brazilian Nacional Cancer Institute with a history of spontaneous discrete bilateral epistaxis once a month showtime when she was 3 years quondam. When she was 14 years old, she started to present with daily profuse bleeding, with no preceding trauma. She had no significant personal or family unit pathological history.
On physical exam, she had normal vital signs and cranial nerve function. On anterior rhinoscopy, she had a mass in the right nasal crenel. An endoscopy with general anesthesia was performed and a mass occupying the right nasal cavity with extension to the nasopharynx, diffusive the septum to the left, was observed.
CT showed an expansive hypervascular mass with well-defined limits occupying the right nasal crenel and nasopharynx. Information technology had nasal septum remodeling and obliteration of maxillary, frontal, sphenoidal, and ethmoidal drainage ostium cells. On MRI, a bulky lobulated mass with well-divers limits and a heterogeneous bespeak, mainly isointense in T2 and slightly hyperintense in T1 and FLAIR, with intense contrast enhancement and menstruum-voids in all sequences, was observed. This hypervascular germination filled the right nasal cavity with posterior extension to the nasopharynx and its fibrous palate surface. No other masses were observed in abdominal ultrasonography and thorax CT (Fig. ane, two). Catecholamine and 24-h urinary metanephrine concentrations were normal, and screening for germline mutations in PGL-1, PGL-2, PGL-3, PGL4, and PGL-v were negative.
Fig. 1
Sagittal MRI shows the mass filling the nasal cavity with extension to the nasopharynx and its fibrous palate surface.
Fig. 2
Centric MRI shows a bulky well-defined mass filling the nasal crenel.
Endonasal biopsy revealed a typical Zellballen blueprint and immunohistochemical staining was positive for synaptophysin with a proliferation alphabetize (Ki-67) of 5% and negative for AE1/AE3, S100, GFAP, CD56, and chromogranin.
Arteriography was performed and a hypervascular lesion nourished by internal maxillary avenue and distal branches of the ophthalmic avenue bilaterally was observed (Fig. iii, four).
Fig. 3
Angiography showing tumor chroma and claret supply from the ophthalmic artery.
Fig. 4
Angiography showing tumor blush and claret supply from the internal maxillary artery.
On the day earlier surgery, she was submitted to arterial embolization with Embozene 500-700® (CeloNova BioSciences Inc., San Antonio, TX, United states) particles of internal maxillary and ascending palatine arteries, with important decrement of tumor vascularization. All the same, there was balance vascularization from the distal branches of the ophthalmic and superficial temporal arteries.
The complete tumor resection was performed by the Weber-Ferguson and Denker approaches, with free margins confirmed by frozen section. There was no meaning bleeding or blood pressure fluctuation during the procedure. Throughout the postoperative setting, the patient had no bleeding or other complications, and the patient was discharged in good clinical condition (Fig. five, 6, 7, 8).
Fig. five
Surgical field demonstrating a Weber-Ferguson approach for the upper cheek flap with delineation of the Denker approach.
Fig. 6
Surgical field demonstrating the tumor partially excised, fixed by its pedicle located at the roof of nasopharynx.
Fig. 7
Tumor specimen totally excised en bloc.
Fig. 8
Advent of the surgical field after resection and hemostasis showing the lateral maxillary sinus wall and the roof of the nasopharynx.
Discussion
Paragangliomas are neuroendocrine tumors originating from pluripotent neural crest stem cells of the autonomic nervous system, known as actress-adrenal paraganglia, which can sally from the skull base to the sacrum [1,two].
Sinonasal paragangliomas are a rare entity which occurs about usually in middle-aged women, with a median age of 45 years. They are often described in patients 40-60 years of historic period, but cases have been reported to range in historic period from 8 to 89 years [1,5,34]. Our patient was 16 years erstwhile, the 2nd youngest age of onset reported.
Hereditary paraganglioma-pheochromocytoma syndromes incorporate PGL1, PGL2, PGL3, PGL4, and PGL5. PGL1 is associated with pheochromocytoma or head and neck paragangliomas, gastrointestinal stromal tumors, and pituitary adenoma, and relates to mutation in the SDHD gene. PGL2 relates to mutation in the SDHAF2 factor and presents as head and neck paraganglioma without other known lesions. PGL3 is related to mutation in the SDHC factor and is associated with head and neck paragangliomas and gastrointestinal stromal tumors. PGL4 relates to mutation in the SDHB factor and the disease could present equally pheochromocytoma or head and neck paraganglioma, gastrointestinal stromal tumors, and renal cell carcinoma. PGL5 correlates with mutation in the SDHD gene and could present with paraganglioma and gastrointestinal stromal tumors [3].
Carney-Stratakis syndrome, or Carney dyad, is autosomal dominant and associated with mutations in the SDHB, SDHC, and SDHD genes. It is characterized by paragangliomas and gastrointestinal stromal tumors. Carney's triad is associated with a combination of 3 rare tumors, gastrointestinal stromal tumors, paraganglioma, and pulmonary chondroma, and adrenal cortical adenoma and esophageal leiomyoma may be present [3].
Head and neck paragangliomas have also been associated with Hippel-Lindau syndrome, which presents with hemangioblastoma, retina adenomas, and renal cancer, and are associated with VHL gene mutation [8].
It has been suggested that genetic testing be proposed to all patients undergoing surgery, guided by family history and clinical findings. The first mutation tested should be guided past clinical presentation. If the beginning is negative, genetic testing should be connected past screening other susceptibility genes [8]. Genetic testing was performed in our patient, merely, despite the early onset, genetic mutations or other clinical findings compatible with whatever genetic syndrome were not observed.
Clinical presentation of these tumors resembles any expansible nasal mass lesion [1]. The almost mutual complaint made past patients with sinonasal paragangliomas are epistaxis and nasal congestion. Despite our patient's tumor size, her main symptom was epistaxis. The youngest patient diagnosed with sinonasal paraganglioma ever reported was an 8-year-old boy with swelling of the left side of the face and a mass in the left turbinate [xx]. Afterwards him, our patient is the 2d youngest patient and the youngest female, with 16 years at diagnosis; yet, she had a suggestive complaint for the previous 13 years. The age of diagnosis is usually between the 5th and seventh decades [34].
CT and MRI are both useful for sinonasal paraganglioma evaluation, and provide complementary information. Regarding os invasion, CT has meliorate operation and can too show calcifications, although MRI is better for exposing soft tissues and its features, such as cellularity profile. Furthermore, MRI demonstrates the tumor'south precise location, size, and extension to adjacent anatomical sites [forty]. The "salt-and-pepper" advent on MRI is of high diagnostic value, with the "salt" images presenting as loftier signal areas, secondary to subacute hemorrhage, while the "pepper" areas are low point intensity flow-voids or vascular channels [41]. The bone remodeling observed on some of these patients is due to the tumor'due south boring growth pattern. Some these features were observed in our case and others have also reported them.
Most case reports describe expansive masses with well-described limits occupying the nasal cavity with a wide spectrum of extension to adjacent sites, just with a bone remodeling blueprint. These are all hypervascular tumors, with contrast enhancement, presenting the classic "salt-and-pepper" appearance and variable patterns of intensity on MRI [5,x,twenty,21,22,23,24,25,26,27,28,29,30,31,32].
On CT, our patient presented an expansive hypervascular mass with well-defined limits occupying the correct nasal crenel and nasopharynx; nasal septum remodeling; and obliteration of the maxillary, frontal, sphenoidal, and ethmoidal drainage ostium cells. On MRI, a bulky lobulated mass with well-divers limits was observed with a heterogeneous signal, mainly isointense in T2 and slightly hyperintense in T1 and FLAIR, with intense contrast enhancement and flow-voids in all sequences. Those findings are compatible with the different cases reported.
Nuclear imaging may besides be required to delineate the extent of the illness [2], as it tin detect possible synchronous lesions in confirmed mutation carriers or those at risk (young age and positive family history) [nine]. Metaiodobenzylguanidine (123I-MIBG) is taken past adrenergic tissues, while pentetreotide binds to the somatostatin receptor; these are likewise known as SPECT scintigraphy [2]. The first, despite its high specificity, has a low sensitivity for caput and neck paragangliomas, and somatostatin receptor scintigraphy has better sensitivity [37,38]. PET imaging sensitivity and resolution are superior to those of SPECT scintigraphy, and it is also a quantitative technique. xviiiF-FDG is the most accessible tracer and it reflects glucose uptake and energy metabolism [2]. Our patient presented with a sporadic instance of nonfunctioning paraganglioma, and since other imaging studies did non demonstrate other tumors, nuclear imaging exams were non necessary.
Differential diagnosis of sinonasal paragangliomas on imaging comprises a broad spectrum of malignant and benign lesions [nine], such as esthesioneuroblastomas, gliomas, angiofibromas, hemangiopericytomas, rhabdomyosarcomas, and metastases from neuroendocrine tumors [xiv].
Esthesioneuroblastoma tumors present as homogeneously enhanced with a dumbbell shape, bone remodeling, and erosion, typically in the midline, centered around the cribriform plate, and are characterized past their peritumoral cyst at the intracranial brain-tumor margin [five].
Gliomas, encephalocele, and dermoid cysts are the virtually mutual congenital midline nasal masses, and their lipomatous content is best visualized nether MRI. Angiofibroma presents with pathognomonic diffuse-homogeneous and dense dissimilarity enhancement without a necrotic or cystic degeneration mass involving the pterygopalatine fossa and posterior nasal crenel, originating from the sphenopalatine foramen [41].
Juvenile nasopharyngeal angiofibroma is a highly vascular tumor, nonencapsulated, and composed of an irregular network of blood vessels and fibroblastic stroma. It almost exclusively occurs in males, peculiarly adolescents, and presents every bit a painless nasal obstacle, epistaxis, and nasopharyngeal mass [42]. Its occurrence in females is then rare that some believe information technology might exist a case of pseudohermaphroditism and sexual activity chromosomes studies should be carried out [43]. Androgen receptors are present in at least 75% of tumors, and some might have progesterone receptors, while estrogen receptors have not been detected [44].
Head and cervix rhabdomyosarcoma arises from the orbits and nasopharynx most normally, usually in children, and 12% involve the sinonasal cavities. This presents as a nonhomogeneous soft tissue mass with os erosion, necrosis, and early-stage intracranial growth [5]. Other highly vascular lesions are hemangioma (exceedingly rare in the nasal crenel and images may show a dearest-rummage advent) and hemangiopericytomas (approximately 2.5% of all vascular sinonasal tumors, mostly heterogeneous, with cystic areas and point-void vessels) [5,42,45,46].
Nuclear imaging may as well be required to delineate the extent of the disease [ii], detecting possible synchronous lesions in confirmed mutation carries or those at gamble (young age and positive family history) [9]. Metaiodobenzylguanidine (¹²³I-MIBG) is taken by adrenergic tissues, while pentetreotide binds to somatostatin receptor; these are besides known as SPECT scintigraphy [2]. The beginning, despite its high specificity, has low sensitivity for head and neck paragangliomas, and somatostatin receptor scintigraphy has better sensitivity [37,38]. PET imaging sensitivity and resolution are superior to those of SPECT scintigraphy, and it is also a quantitative technique. ¹eightF-FDG is the almost accessible tracer and it reflects glucose uptake and energy metabolism [two]. Our patient presented with a sporadic case of nonfunctioning paraganglioma and other imaging studies did not demonstrate other tumors; nuclear imaging exams were not necessary.
For tumors larger than 3 cm, preoperative hyperselective embolization is brash, preventing major blood loss during surgery [47]. Despite this recommendation, about cases described accept not reported embolization previous to the resection.
Several embolic agents have been described and the choice of the embolic textile depends on the target, size of the feeding arteries, blood flow blueprint, and potentially threatening anastomoses or collateral vessels. Embolic agents might be permanent or temporary. Nonabsorbable materials achieve more durable obstruction and are well suited for vascular lesions [48]. Particulate embolics are the most frequently used particulate embolic agents in modern treatment of head and neck pathology. They have a wide range of diameters, allowing control over depth of vascular penetration. Absorbable gelatin pledgets are not as effective in microvascular penetration, equally they provide less complete devascularization of tumor beds and the nasal cavity [49].
Our patient was submitted to embolization of the bilateral internal maxillary artery and left ascending palatine artery with Embozene 500-700® particles, leading to an of import reduction of the tumor'due south vascularization. There was residue vascularization from intracavernous carotid avenue branches, mainly from the right distal branches of ophthalmic artery bilaterally, and a distal branch from the right superficial temporal artery. Embozene® particles are spherical and consist of a hydrogel core and apoly(bis[trifluoroethoxy]phosphazene) nanocoat with low inflammatory response [fifty].
The classic Zellballen pattern is shown in almost paragangliomas, with cell nests separated by capillaries and sustentacular cells at its periphery [51]. This design was observed in our case, but an uncommon morphology was described with lipoblast-vacuolated cells instead of the typical pattern [23]. Other variations in the tumor architecture include diffuse and trabecular growth patterns, extensive sclerosis that may mimic invasive carcinoma, and unusual vascular patterns that can mimic angiomas [51].
In immunohistochemical staining, neuroendocrine markers such every bit chromogranin, synaptophysin, and neuron-specific enolase may be positive [52]. Chromogranin seems to exist present in about or all paragangliomas, and is thus a useful marker. However, it may fail to stain degranulated cells [22]. Peripheral sustentacular cells demonstrate positivity for S100 protein. Immunohistochemical staining of head and cervix paragangliomas tin exist negative or focally positive for chromogranin A and tyrosine hydroxylase, and sometimes preferably express chromogranin B. The absence of tyrosine hydroxylase explains the usual nonfunctionality of these tumors [51]. Immunohistochemical analysis of our patient'south specimen showed positivity only for synaptophysin, and was negative for S100 and chromogranin, which is a uniform blueprint for head and cervix paraganglioma.
The recognition of malignant and benign paraganglioma by morphologic features is difficult considering at that place is no specific parameter to differ both. Yet, a tumor'southward biologic evaluations have shown that malignant paragangliomas testify a higher charge per unit of aneuploidy, upregulated expression of CD44 v4/5, which is a mark for an infiltrative growth pattern of a tumor [34].
Sinonasal paragangliomas can show locally disruptive beliefs, with recurrence and invasion of sites such equally the frontal sinus and orbit [53]. This has been described in over 26% of metastasis on theses tumors. Additionally, histological features may not be plenty to distinguish benign from malignant paraganglioma since there is no particular morphologic character for malignancy [34]. The malignant character of paraganglioma must be defined by the presence of metastasis to cervical lymph nodes or distant organs [1].
In lite of the facts explained above, sinonasal paragangliomas must be resected, aiming for free margins. Small tumors tin can be resected through the endonasal arroyo, but bleeding command can be difficult, even when preoperative embolization is performed [26]. Based on our patient's tumor extension and vascularity blueprint, conventional surgery with preoperative embolization was the treatment of choice. Traditional sinonasal open approaches for sinonasal paraganglioma should be tailored by tumor location and extension. Information technology may be performed by lateral rhinotomy incision, which can be extended with a Weber-Ferguson incision [54]. Lateral rhinotomy provides excellent exposure to the nasal crenel, paranasal sinuses, and nasopharynx with minimal postoperative deformity [55]. Other approaches consist of midfacial degloving, which is suited for extensive lesions in the nasal cavity, ethmoid and sphenoid sinuses, nasopharynx, and infratemporal fossa, avoiding external incision. On the other hand, information technology may exist associated with upward rotation of the nasal tip [56]. The Denker approach, which consists of a broad anterior antrostomy with the removal of the ascending procedure of the maxilla and the inferior half of the lateral nasal wall, can be associated with the previous approach without late complications [57]. The Weber-Ferguson incision combined with the Denker approach was performed, due to its splendid exposure, skilful aesthetical results, and lack of major complications.
Radiation therapy may control the disease by slowing its growth rate, just it does not provide a cure. Tumor control with radiotherapy is defined every bit a lack of progression, and complete remission is very rare. The control rate decreases with time. In skull base tumors, stereotactic radiotherapy has been reported favorably. Nevertheless, information technology has been advocated for unresectable tumors, positive margins after tumor resection, or in cases with ambitious beliefs or a histological pattern [ix].
Chemotherapy also has not demonstrated acceptable efficacy [34]. Somatostatin analogue handling for tumors positive for its receptor has also not shown an important do good [58]. Mod antiangiogenic medications may take some promise, merely only for paragangliomas of sites other than the head and cervix [59]. Peptide receptor radionuclide therapy with radiolabeled agents (metaiodobenzylguanidine or somatostatin analogue) is an option for malignant or unresectable paragangliomas with up to half of the cases showing symptomatic and partial tumor response [9]. Everolimus inhibits mammalian target of rapamycin, a serine-threonine kinase that stimulates cell growth, proliferation, and angiogenesis [sixty]. A stage Two study evaluating the outcome of everolimus in neuroendocrine tumors demonstrated that everolimus treatment presented with high efficacy and tolerability in patients with nonfunctioning neuroendocrine tumors, but discreet effectiveness in patients with pheochromocytoma/paraganglioma [61].
Follow-up must be carried out for long periods and the time interval betwixt initial treatment and metastasis occurrence has been reported to exist every bit long equally 13 years. There is no gilt standard imaging, but CT, MRI, and 18F-FDG PET/CT take been suggested as outset-line exams to appraise locoregional extension and/or metastatic lesions [14].
Conclusion
Paragangliomas are infrequent neuroendocrine tumors that may ascend from the skull base of operations from the sacrum. Sinonasal paragangliomas are very rare and must be differentiated from other benign and malignant tumors of this site, such equally esthesioneuroblastomas, gliomas, angiofibromas, hemangiopericytomas, rhabdomyosarcomas, or metastases from neuroendocrine tumors.
Diagnostic investigation includes catecholamine excess evaluation, CT, and MRI. Nuclear imaging may be required for secondary lesion investigation. Genetic mutations take been described in paraganglioma patients, and those with early onset should be evaluated when genetic testing is available.
Both endoscopic and open conventional approaches are constructive in sinonasal paragangliomas, and preoperative embolization is paramount for reducing bleeding take a chance. Radiotherapy may control the disease by slowing its progression, but cure is unlikely to exist achieved. Chemotherapy efficacy has not been demonstrated and peptide receptor radionuclide therapy may be an option in the future for cancerous and unresectable paragangliomas.
Histopathological features cannot differentiate benign from malignant paragangliomas, and metastasis may occur at a tardily phase of the affliction. Follow-up must exist carried out with thorough imaging investigation for long periods.
The instance presented above is the second youngest reported case. It was diagnosed by endoscopic biopsy, CT, and MRI, demonstrating a large nasal cavity paraganglioma. Our patient was submitted to preoperative embolization with particles and open up conventional surgery by the Weber-Ferguson and Denker approaches, with total en bloc resection with free margins and an excellent final effect, without postoperative complications.
Acknowledgements
The authors would like to thank the Research Center of Brazilian National Cancer Plant.
Disclosure Statement
The authors report no conflicts of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
This commodity is licensed under the Artistic Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified cloth requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accordance with current recommendations and practice at the time of publication. Nevertheless, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is especially important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The advent of advertisements or/and product references in the publication is non a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or rubber. The publisher and the editor(s) disclaim responsibleness for any injury to persons or property resulting from whatever ideas, methods, instructions or products referred to in the content or advertisements.
Source: https://www.karger.com/Article/Fulltext/464099
0 Response to "Malignant Nasal Paraganglioma a Case Report and Review of the Literature"
Post a Comment